Teva Sues Mylan, Natco Over Copaxone ANDA
Teva Pharmaceutical Industries Ltd. has hit Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. with a patent infringement suit over their plans for a generic version of the multiple sclerosis therapy drug...To view the full article, register now.
Already a subscriber? Click here to view full article